Universitat de Lleida
    • English
    • català
    • español
  • català 
    • English
    • català
    • español
  • Inicia la sessió
Repositori Obert UdL
Visualitza l'element 
  •   Inici
  • Recerca
  • Medicina
  • Articles publicats (Medicina)
  • Visualitza l'element
  •   Inici
  • Recerca
  • Medicina
  • Articles publicats (Medicina)
  • Visualitza l'element
JavaScript is disabled for your browser. Some features of this site may not work without it.

Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Eventsin Nonsleepy Patients With Obstructive Sleep Apnea

Thumbnail
Visualitza/Obre
019356.pdf (324.1Kb)
Data de publicació
2013
Autor/a
Barbé Illa, Ferran
Durán-Cantolla, Joaquín
Sánchez de la Torre, Manuel
Martínez Alonso, Montserrat
Carmona, Carmen
Barceló Bennasar, Antònia
Chiner, Eusebi
Masa, Juan Fernando
González, Mónica
Marín, J. M.
García Río, Francisco
Díaz de Atauri, María Josefa
Terán, Joaquin
Mayós Pérez, Mercè
Peña, Mónica de la
Monasterio, Carmen
Campo, Félix del
Montserrat i Capdevila, Josep
Citació recomanada
Barbé Illa, Ferran; Durán-Cantolla, Joaquín; Sánchez de la Torre, Manuel; Martínez Alonso, Montserrat; Carmona, Carmen; Barceló Bennasar, Antònia; ... Montserrat i Capdevila, Josep. (2013) . Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Eventsin Nonsleepy Patients With Obstructive Sleep Apnea. JAMA, 2013, vol. 307, núm. 20, p.2161-2168. https://doi.org/10.1001/jama.2012.4366.
Impacte


Logo de Web of Science    citacions a Web of Science

Logo d'Scopus    citacions a Scopus

Logo de Google Acadèmic  Google Acadèmic
Compartir
Exportar a Mendeley
Metadades
Mostra el registre d'unitat complet
Resum
Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with sleep-disordered breathing, regardless of daytime symptoms, is unclear. Objective To evaluate the effect of CPAP treatment on the incidence of hypertension or cardiovascular events in a cohort of nonsleepy patients with OSA. Design, Setting, and Patients Multicenter, parallel-group, randomized controlled trial in 14 teaching hospitals in Spain. Between May 2004 and May 2006, 725 consecutive patients were enrolled who had an apnea-hypopnea index of 20 h−1 or greater and an Epworth Sleepiness Scale score of 10 or less (scores range from 0-24, with values 10 suggesting no daytime sleepiness). Exclusion criteria were previous cardiovascular event, physical or psychological incapacity, chronic disease, or drug or alcohol addiction. Follow-up ended in May 2009. Intervention Patients were allocated to receive CPAP treatment or no active intervention. All participants received dietary counseling and sleep hygiene advice. Main Outcome Measures Incidence of either systemic hypertension (taking antihypertensive medication or blood pressure greater than 140/90 mm Hg) or cardiovascular event (nonfatal myocardial infarction, nonfatal stroke, transient ischemic attack, hospitalization for unstable angina or arrhythmia, heart failure, or cardiovascular death). Results Seven hundred twenty-three patients underwent follow-up for a median of 4 (interquartile range, 2.7-4.4) years (1 patient from each group did not receive allocated treatment); 357 in the CPAP group and 366 in the control group were included in the analysis. In the CPAP group there were 68 patients with new hypertension and 28 cardiovascular events (17 unstable angina or arrhythmia, 3 nonfatal stroke, 3 heart failure, 2 nonfatal myocardial infarction, 2 transient ischemic attack, 1 cardiovascular death). In the control group there were 79 patients with new hypertension and 31 cardiovascular events (11 unstable angina or arrhythmia, 8 nonfatal myocardial infarction, 5 transient ischemic attack, 5 heart failure, 2 nonfatal stroke). The hypertension or cardiovascular event incidence density rate was 9.20 per 100 person-years (95% CI, 7.36-11.04) in the CPAP group and 11.02 per 100 person-years (95% CI, 8.96-13.08) in the control group. The incidence density ratio was 0.83 (95% CI, 0.63-1.1; P=.20). Conclusions In patients with OSA without daytime sleepiness, the prescription of CPAP compared with usual care did not result in a statistically significant reduction in the incidence of hypertension or cardiovascular events. However, the study may have had limited power to detect a significant difference.
URI
http://hdl.handle.net/10459.1/56684
DOI
https://doi.org/10.1001/jama.2012.4366
És part de
JAMA, 2013, vol. 307, núm. 20, p.2161-2168
Projectes de recerca europeus
Col·leccions
  • Articles publicats (Medicina) [469]
  • Articles publicats (Ciències Mèdiques Bàsiques) [559]
  • Articles publicats (IRBLleida) [1083]

Contacteu amb nosaltres | Envia comentaris | Avís legal
© 2022 BiD. Universitat de Lleida
Metadades subjectes a 
 

 

Explora

Tot el repositoriComunitats i col·leccionsPer data d'edicióAutorsTítolsMatèriesAquesta col·leccióPer data d'edicióAutorsTítolsMatèries

Estadístiques

Veure estadístiques d'ús

D'interès

Política institucional d'accés obertDiposita les teves publicacionsDiposita dades de recercaSuport a la recerca

Contacteu amb nosaltres | Envia comentaris | Avís legal
© 2022 BiD. Universitat de Lleida
Metadades subjectes a